MediFind found 5 doctor with experience in Chronic T-Cell Leukemia (CTCL) near New Haven, CT. Of these, 4 are Experienced and 1 are Advanced.
Yale University
Francine Foss is an Oncologist in New Haven, Connecticut. Dr. Foss is rated as an Advanced provider by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). Her top areas of expertise are Peripheral T-Cell Lymphoma, T-Cell Lymphoma, Non-Hodgkin Lymphoma, and Cutaneous T-Cell Lymphoma (CTCL).
Yale University
Lohith Gowda is a Hematologist and a Transfusion Medicine provider in New Haven, Connecticut. Dr. Gowda is rated as an Experienced provider by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). His top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Multiple Myeloma, Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Transplant.
Yale University
Daniel Boxer is a Hematologist Oncology specialist and an Oncologist in New Haven, Connecticut. Dr. Boxer is rated as an Experienced provider by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). His top areas of expertise are Anemia, Childhood Iron Deficiency Anemia, Pleuropulmonary Blastoma, Lung Cancer, and Splenectomy.
Yale New Haven Hospital
Henry Rinder is an Internal Medicine provider in New Haven, Connecticut. Dr. Rinder is rated as an Experienced provider by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). His top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Chronic Lymphocytic Leukemia (CLL), and Multiple Myeloma.
Yale University
Stuart Seropian is an Oncologist in New Haven, Connecticut. Dr. Seropian is rated as an Experienced provider by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). His top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Multiple Myeloma, Tissue Biopsy, and Bone Marrow Aspiration.
To see more doctors, please expand your search radius or view related conditions below.
Last Updated: 01/09/2026
